Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
130
NCT02021474
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of Subcutaneous AGX-201 for Migraine Prophylaxis
Phase: Phase 2
Role: Lead Sponsor
Start: Oct 31, 2022
Completion: Jul 31, 2023